These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34696184)

  • 21. Antibodies against refolded recombinant envelope protein (domain III) of Japanese encephalitis virus inhibit the JEV infection to Porcine Stable Kidney cells.
    Verma SK; Gupta N; Pattnaik P; Babu JP; Rao PV; Kumar S
    Protein Pept Lett; 2009; 16(11):1334-41. PubMed ID: 20001924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection of swine by potent neutralizing anti-Japanese encephalitis virus monoclonal antibodies derived from vaccination.
    Young CL; Lyons AC; Hsu WW; Vanlandingham DL; Park SL; Bilyeu AN; Ayers VB; Hettenbach SM; Zelenka AM; Cool KR; Peterson GJ; Higgs S; Huang YS
    Antiviral Res; 2020 Feb; 174():104675. PubMed ID: 31825852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China.
    Liu X; Yu Y; Li M; Liang G; Wang H; Jia L; Dong G
    Vaccine; 2011 Mar; 29(11):2127-30. PubMed ID: 21237278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel amino acid site closely associated with the neurovirulence of live, attenuated Japanese encephalitis vaccine (SA14-14-2 strain).
    Yang H; Fan F; Liu L; Liu J; Sun Y; Xie A; Shi X; Liu L; Yu Y; Li Y; Ge Y; Zeng X; Yang H
    Vaccine; 2020 Mar; 38(11):2636-2642. PubMed ID: 32044162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotype v Japanese encephalitis virus is emerging.
    Li MH; Fu SH; Chen WX; Wang HY; Guo YH; Liu QY; Li YX; Luo HM; Da W; Duo Ji DZ; Ye XM; Liang GD
    PLoS Negl Trop Dis; 2011 Jul; 5(7):e1231. PubMed ID: 21750744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction and immune efficacy of recombinant pseudorabies virus expressing PrM-E proteins of Japanese encephalitis virus genotype І.
    Qian P; Zhi X; Wang B; Zhang H; Chen H; Li X
    Virol J; 2015 Dec; 12():214. PubMed ID: 26651827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Live chimeric and inactivated Japanese encephalitis virus vaccines differ in their cross-protective values against Murray Valley encephalitis virus.
    Lobigs M; Larena M; Alsharifi M; Lee E; Pavy M
    J Virol; 2009 Mar; 83(6):2436-45. PubMed ID: 19109382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.
    Erra EO; Askling HH; Yoksan S; Rombo L; Riutta J; Vene S; Lindquist L; Vapalahti O; Kantele A
    Vaccine; 2013 Dec; 32(1):119-23. PubMed ID: 24176496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine.
    Fan YC; Chen JM; Chiu HC; Chen YY; Lin JW; Shih CC; Chen CM; Chang CC; Chang GJ; Chiou SS
    PLoS Negl Trop Dis; 2012; 6(9):e1834. PubMed ID: 23029592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotype-specific neutralization determinants in envelope protein: implications for the improvement of Japanese encephalitis vaccine.
    Ye Q; Xu YP; Zhang Y; Li XF; Wang HJ; Liu ZY; Li SH; Liu L; Zhao H; Nian QG; Deng YQ; Qin ED; Qin CF
    J Gen Virol; 2015 Aug; 96(8):2165-2175. PubMed ID: 25908779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced neutralizing antibody titer against genotype I virus in swine immunized with a live-attenuated genotype III Japanese encephalitis virus vaccine.
    Fan YC; Chen JM; Chen YY; Lin JW; Chiou SS
    Vet Microbiol; 2013 May; 163(3-4):248-56. PubMed ID: 23415032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
    Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
    J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chimeric Japanese Encephalitis Virus SA14/SA14-14-2 Was Virulence Attenuated and Protected the Challenge of Wild-Type Strain SA14.
    Huang R; Leng S; Feng Y; Tang L; Yuan L; Yang J
    Can J Infect Dis Med Microbiol; 2019; 2019():9179308. PubMed ID: 30944684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Japanese encephalitis virus E and NS1 proteins immunogenicity using a recombinant Newcastle disease virus in mice.
    Nath B; Vandna ; Saini HM; Prasad M; Kumar S
    Vaccine; 2020 Feb; 38(7):1860-1868. PubMed ID: 31955960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced Immune Responses Against Japanese Encephalitis Virus Infection Using Japanese Encephalitis Live-Attenuated Virus Adjuvanted with Montanide GEL 01 ST in Mice.
    Xu Y; Wang Q; Wei B; Huang X; Wen Y; Yan Q; Ma X; Zhao Q; Cao S; Huang Y; Wen X; Han X; Bai Y; Wu R
    Vector Borne Zoonotic Dis; 2019 Nov; 19(11):835-843. PubMed ID: 31314706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
    Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S
    Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia.
    Schuh AJ; Ward MJ; Leigh Brown AJ; Barrett AD
    J Virol; 2014 Apr; 88(8):4522-32. PubMed ID: 24501419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.
    Konishi E; Kurane I; Mason PW; Shope RE; Ennis FA
    Virology; 1997 Jan; 227(2):353-60. PubMed ID: 9018134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adaptation of a live-attenuated genotype I Japanese encephalitis virus to vero cells is associated with mutations in structural protein genes.
    Anwar MN; Guo S; Xin W; Hameed M; Wahaab A; Ma X; Khan AU; Rahman SU; Shao D; Li Z; Liu K; Li B; Qiu Y; Ma Z; Wei J
    Virus Res; 2021 Jan; 292():198256. PubMed ID: 33285172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses.
    Lobigs M; Pavy M; Hall RA; Lobigs P; Cooper P; Komiya T; Toriniwa H; Petrovsky N
    J Gen Virol; 2010 Jun; 91(Pt 6):1407-17. PubMed ID: 20130134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.